Publication Name	World Journal of Clinical Cases
Manuscript ID	64989
Country	China

Received	2021-02-28 12:26
Peer-Review Started	2021-02-28 12:28
To Make the First Decision
Return for Revision	2021-06-07 00:18
Revised	2021-06-10 04:39
Second Decision	2021-07-12 03:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-07-12 06:12
Articles in Press	2021-07-12 06:12
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-11-30 12:36
Typeset the Manuscript	2021-12-26 15:31
Publish the Manuscript Online	2021-12-30 08:21

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	HER2 turns to positive after neoadjuvant chemotherapy in breast cancer: A case report and review of literature
Manuscript Source	Unsolicited Manuscript
All Author List	Luo Wang, Qi Jiang, Meng-Ye He and Peng Shen
ORCID	Author(s) ORCID Number Luo Wang http://orcid.org/0000-0001-8837-9606 Qi Jiang http://orcid.org/0000-0001-7236-1014 Meng-Ye He http://orcid.org/0000-0003-0567-0399 Peng Shen http://orcid.org/0000-0002-1123-9848
Funding Agency and Grant Number
Corresponding Author	Peng Shen, MD, Doctor, Department of Medical Oncology, The first Affliated Hospital,College of Medicine,Zhejiang University, No. 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. shenp@zju.edu.cn
Key Words	Carcinoma; Ductal; Breast; Neoadjuvant therapy; Biomarkers, Tumor; Case report
Core Tip	Precise molecular subtype of breast cancer is helpful to make individualized strategies for systemic treatment, we thus pay more attention to the changes of tumor biomarkers before and after surgery. The conversion probability is fairly low, especially in HER2 status, however, it directly affects the formulation of adjuvant treatment. A more important fact is that anti-HER2 therapy has led to a landmark change in patients with HER2 positive breast cancer.
Publish Date	2021-12-30 08:21
Citation	Wang L, Jiang Q, He MY, Shen P. HER2 turns to positive after neoadjuvant chemotherapy in breast cancer: A case report and review of literature. World J Clin Cases 2022; 10(1): 260-267
URL	https://www.wjgnet.com/2307-8960/full/v10/i1/260.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i1.260

Full Article (PDF)	WJCC-10-260.pdf
Full Article (Word)	WJCC-10-260.docx
Manuscript File	64989_Auto_Edited-JPY-Webster J.docx
Answering Reviewers	64989-Answering reviewers.pdf
Audio Core Tip	64989-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	64989-Conflict-of-interest statement.pdf
Copyright License Agreement	64989-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	64989-Informed consent statement.pdf
Peer-review Report	64989-Peer-review(s).pdf
Scientific Misconduct Check	64989-Scientific misconduct check.pdf
Scientific Editor Work List	64989-Scientific editor work list.pdf